@misc{indiciae63c3d99103bb,
  title = {ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in early stage Gallbladder Cancer},
  author = {Iyer, P. and Shrikhande, S. V. and Ranjan, M. and Joshi, A. and Prasad, R. and Gardi, N. and Thorat, R. and Salunkhe, S. and Dharavath, B. and Sahoo, B. and Chandrani, P. and Kore, H. and Mohanty, B. and Chaudhari, V. and Choughule, A. and Kawle, D. and Chaudhari, P. and Ingle, A. and Banavali, S. and Ramadwar, M. R. and Prabhash, K. and Barreto, S. G. and Dutt, S. and Dutt, A.},
  year = {2018},
  doi = {10.1101/290486},
  url = {https://www.biorxiv.org/content/10.1101/290486v1},
  note = {Source identifier: 10.1101/290486}
}